Cabozantinib plus atezolizumab improved progression-free survival in advanced prostate cancer after ARPI failure.

A Lincolnshire man will be walking more than 170 miles in tribute to his niece who has a very rare and inoperable cancer.

Due to an overwhelming response, a blood drive held in honor of an Erie woman battling cancer was extended for a second day.